The study of decitabine combination with aclarubicin and cytarabine and granulocyte colony-stimulating factor on the outcome of elderly patients with acute myeloid leukaemia.
Phase of Trial: Phase II
Latest Information Update: 22 Apr 2016
At a glance
- Drugs Decitabine (Primary) ; Aclarubicin; Cytarabine; Granulocyte colony-stimulating factors
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 21 May 2012 Planned end date 15 Sep 2016 added as reported by Chinese Clinical Trial Register.
- 14 Nov 2011 New trial record